ZYNEX INC (OTCMKTS:ZYXI) Sellers Declined By 83.49% Their Shorts As Of Dec 8, 2018

Change of 83.49% for ZYNEX INC (OTCMKTS:ZYXI)’s shorted shares was showed. In December was announced ZYXI’s total 7,000 shorted shares by FINRA. That’s 83.49% down from 42,400 shares. 0 days will cost ZYXI with 75,000 average volume to restore its previous position.

ZYXI is reaching $3.1 during the last trading session, after increased 2.65%.Zynex, Inc. has 35,272 shares volume, 107.48% up from normal. ZYXI is and has moved 0.00% since December 8, 2017. ZYXI underperformed by 15.62% the S&P500.

Zynex, Inc., through its subsidiaries, designs, makes, and markets electrotherapy medical devices used for pain management and rehabilitation.The firm is valued at $100.41 million. The Company’s products include NexWave, a dual channel, multi-modality interferential current, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence.The P/E ratio is 10.4. The firm also distributes private labeled products comprising electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products.

Another two news for Zynex, Inc. (OTCMKTS:ZYXI) were recently released by: Seekingalpha.com on May 10, 2018 with title “Zynex, Inc. 2018 Q1 – Results – Earnings Call Slides – Seeking Alpha”. The other Seekingalpha.com‘s article was titled “Zynex: Spectacular Turnaround, Conservative Investor Response (So Far) – Seeking Alpha” and released on August 17, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.